Evotec (EVO) And Variant Bio Enter Strategic Partnership To Discover And Develop Fibrosis Treatments Apr 18, 2024 07:27AM
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS Apr 18, 2024 07:27AM
Exscientia Presents Novel Immuno-Oncology Biomarker for EXS-21546 at the ESMO I-O Annual Congress Dec 6, 2022 07:00AM
Exscientia plc (EXAI) Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours Nov 28, 2022 07:01AM
Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours Nov 28, 2022 07:00AM


Oct 17, 2022 07:00AM TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen
Sep 21, 2022 06:00AM Adapsyn Bioscience enters into strategic collaboration with Evotec
Aug 10, 2022 01:30AM Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303
Jun 14, 2022 08:04AM Exscientia plc (EXAI) Reports Topline Data From EXS-21546 Phase 1a Study Demonstrating Targeted A2A Receptor Signaling Inhibition in Healthy Volunteers
Jun 14, 2022 08:00AM Exscientia Reports Topline Data From EXS-21546 Phase 1a Study Demonstrating Targeted A2A Receptor Signaling Inhibition in Healthy Volunteers
Nov 18, 2021 07:00AM EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership
Jan 25, 2021 04:05PM I-Mab and MorphoSys Announce First Patient Dosed in U.S. Phase 1 Study of TJ210/MOR210 in Patients with Advanced Cancer
Jun 24, 2020 07:00AM Samsara BioCapital, Evotec and KCK Launch Autobahn Labs, a Novel Early Stage Drug Discovery Incubator
Jan 23, 2020 03:00AM Evotec and Indivumed Announce Second Joint Drug Discovery Program
Sep 30, 2019 08:00AM Evotec And Indivumed Achieve Milestone In Joint Strategic Drug Discovery Collaboration
Oct 17, 2018 01:00AM Ferring and Evotec Form Strategic Research Alliance in Reproductive Medicine and Women’s Health